Tracy TS and Johns M |
Comment: delirium probably induced by clarithromycin in a patient receiving fluoxetine. |
1996 |
Ann Pharmacother |
pmid:8893135
|
Wintermeyer SM et al. |
Dirithromycin: a new macrolide. |
1996 |
Ann Pharmacother |
pmid:8893122
|
Hunt Gerardo S et al. |
Comparison of Etest to broth microdilution method for testing Streptococcus pneumoniae susceptibility to levofloxacin and three macrolides. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8891154
|
Patel KB et al. |
Comparison of bronchopulmonary pharmacokinetics of clarithromycin and azithromycin. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8891147
|
Tateda K et al. |
Direct evidence for antipseudomonal activity of macrolides: exposure-dependent bactericidal activity and inhibition of protein synthesis by erythromycin, clarithromycin, and azithromycin. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8891128
|
Giacometti A et al. |
In-vitro activity of macrolides alone and in combination with artemisin, atovaquone, dapsone, minocycline or pyrimethamine against Cryptosporidium parvum. |
1996 |
J. Antimicrob. Chemother. |
pmid:8889715
|
Tursi A et al. |
One-week low-dose triple therapy vs. two-week medium-dose double therapy for H.pylori infection. |
1996 Jul-Aug |
Hepatogastroenterology |
pmid:8884304
|
Ji B et al. |
Bactericidal activity of single dose of clarithromycin plus minocycline, with or without ofloxacin, against Mycobacterium leprae in patients. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8878595
|
Pankuch GA et al. |
MIC and time-kill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 59500 (quinupristin-dalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptible and -resistant pneumococci. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8878583
|
Wenisch C et al. |
Effect of single oral dose of azithromycin, clarithromycin, and roxithromycin on polymorphonuclear leukocyte function assessed ex vivo by flow cytometry. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8878577
|
McLinn S and Williams D |
Incidence of antibiotic-resistant Streptococcus pneumoniae and beta-lactamase-positive Haemophilus influenzae in clinical isolates from patients with otitis media. |
1996 |
Pediatr. Infect. Dis. J. |
pmid:8878239
|
Thor P et al. |
Dysfunction in gastric myoelectric and motor activity in Helicobacter pylori positive gastritis patients with non-ulcer dyspesia. |
1996 |
J. Physiol. Pharmacol. |
pmid:8877902
|
Tursi A et al. |
Helicobacter pylori eradication helps resolve pyloric and duodenal stenosis. |
1996 |
J. Clin. Gastroenterol. |
pmid:8877648
|
Dhaenens L et al. |
In-vitro activities of clarithromycin and other antimicrobial agents against Helicobacter pylori isolated from children. |
1996 |
J. Antimicrob. Chemother. |
pmid:8877551
|
Fisher M et al. |
The management of mycobacterial infections in HIV seropositive individuals. Jefferiss Wing Therapeutics and Protocols Group. |
1996 |
Int J STD AIDS |
pmid:8876354
|
Yousfi MM et al. |
Metronidazole, ranitidine and clarithromycin combination for treatment of Helicobacter pylori infection (modified Bazzoli's triple therapy). |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8871452
|
Ferguson PJ and Saulsbury FT |
Successful treatment of chronic Mycobacterium abscessus otitis media with clarithromycin. |
1996 |
Pediatr. Infect. Dis. J. |
pmid:8866816
|
Xu G et al. |
Effect of macrolide antibiotics on macrophage functions. |
1996 |
Microbiol. Immunol. |
pmid:8865152
|
Hackelsberger A and Malfertheiner P |
A risk-benefit assessment of drugs used in the eradication of Helicobacter pylori infection. |
1996 |
Drug Saf |
pmid:8862962
|
Chiba N |
Omeprazole and clarithromycin with and without metronidazole for the eradication of Helicobacter pylori. |
1996 |
Am. J. Gastroenterol. |
pmid:8855737
|
Schimkat M et al. |
Rifabutin-associated anterior uveitis in patients infected with human immunodeficiency virus. |
1996 |
Ger J Ophthalmol |
pmid:8854102
|
Yousfi MM et al. |
One-week triple therapy with omeprazole, amoxycillin and clarithromycin for treatment of Helicobacter pylori infection. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8853767
|
Cone LA et al. |
Mania due to clarithromycin therapy in a patient who was not infected with human immunodeficiency virus. |
1996 |
Clin. Infect. Dis. |
pmid:8853002
|
Dammann HG |
[Helicobacter pylori eradication: triple therapy versus dual therapy]. |
1996 |
Fortschr. Med. |
pmid:8852685
|
Vermot D et al. |
Efficacy of clarithromycin versus that of clindamycin for single-dose prophylaxis of experimental streptococcal endocarditis. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8851620
|
Amsden GW |
Erythromycin, clarithromycin, and azithromycin: are the differences real? |
1996 Jan-Feb |
Clin Ther |
pmid:8851453
|
O'Hara K and Yamamoto K |
Reaction of roxithromycin and clarithromycin with macrolide-inactivating enzymes from highly erythromycin-resistant Escherichia coli. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8849224
|
Liviu L et al. |
Pancreatitis induced by clarithromycin. |
1996 |
Ann. Intern. Med. |
pmid:8849171
|
Ednie LM et al. |
Comparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneumococci. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8843313
|
Rana KZ et al. |
Clarithromycin does not affect phosphorylation of zidovudine in vitro. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8843311
|
Alper CM et al. |
Efficacy of clarithromycin treatment of acute otitis media caused by infection with penicillin-susceptible, -intermediate, and -resistant Streptococcus pneumoniae in the chinchilla. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8843299
|
Heifets L |
Susceptibility testing of Mycobacterium avium complex isolates. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8843278
|
Yousfi MM et al. |
Resolution of a metaplastic duodenal polyp after cure of Helicobacter pylori infection. |
1996 |
J. Clin. Gastroenterol. |
pmid:8835902
|
Versalovic J et al. |
Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8834903
|
Dattwyler RJ et al. |
Clarithromycin in treatment of early Lyme disease: a pilot study. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8834900
|
Ji B et al. |
How effective is KRM-1648 in treatment of disseminated Mycobacterium avium complex infections in beige mice? |
1996 |
Antimicrob. Agents Chemother. |
pmid:8834894
|
Yamamoto T et al. |
Activity of KRM-1648 alone or in combination with both ethambutol and kanamycin or clarithromycin against Mycobacterium intracellulare infections in beige mice. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8834892
|
Ji B et al. |
Bactericidal activities of combinations of new drugs against Mycobacterium leprae in nude mice. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8834886
|
Vangala R and Cernek PK |
Hypersensitivity reaction to clarithromycin. |
1996 |
Ann Pharmacother |
pmid:8833572
|
Erah PO et al. |
Ion-pair high-performance liquid chromatographic assay method for the assessment of clarithromycin stability in aqueous solution and in gastric juice. |
1996 |
J. Chromatogr. B, Biomed. Appl. |
pmid:8832427
|
Piersimoni C et al. |
Activity of seven antimicrobial agents, alone and in combination, against AIDS-associated isolates of Mycobacterium avium complex. |
1995 |
J. Antimicrob. Chemother. |
pmid:8830013
|
Webb DD |
Practice guidelines for treatment of peptic ulcer disease. |
1996 |
JAMA |
pmid:8827959
|
Pijpers E et al. |
A clarithromycin-induced myasthenic syndrome. |
1996 |
Clin. Infect. Dis. |
pmid:8824993
|
Xu G et al. |
[Effect of clarithromycin on cytocidal activity against Pseudomonas aeruginosa in mice peritoneal cavity]. |
1996 |
Kansenshogaku Zasshi |
pmid:8822058
|
Nishi K et al. |
[Effect of clarithromycin on symptoms and mucociliary transport in patients with sino-bronchial syndrome]. |
1995 |
Nihon Kyobu Shikkan Gakkai Zasshi |
pmid:8821993
|
Sketris IS et al. |
Possible role of the intestinal P-450 enzyme system in a cyclosporine-clarithromycin interaction. |
1996 Mar-Apr |
Pharmacotherapy |
pmid:8820476
|
Nash KA and Inderlied CB |
Rapid detection of mutations associated with macrolide resistance in Mycobacterium avium complex. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8807078
|
Gillum JG et al. |
Effect of combination therapy with ciprofloxacin and clarithromycin on theophylline pharmacokinetics in healthy volunteers. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8807068
|
Wallace RJ et al. |
Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8807061
|
Conte JE et al. |
Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8807050
|
Goh KL et al. |
Helicobacter pylori eradication with short-term therapy leads to duodenal ulcer healing without the need for continued acid suppression therapy. |
1996 |
Eur J Gastroenterol Hepatol |
pmid:8804868
|
Papp J et al. |
Efficacy of nizatidine, clarithromycin and bismuth subcitrate therapy for Helicobacter pylori eradication in duodenal ulcer patients--a preliminary report. |
1996 Jul-Aug |
Br J Clin Pract |
pmid:8794601
|
Tursi A et al. |
Low-dose omeprazole plus clarithromycin and either tinidazole or amoxycillin for Helicobacter pylori infection. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8791952
|
Weldon MJ et al. |
A seven-day Helicobacter pylori treatment regimen using clarithromycin, omeprazole and tripotassium dicitrato bismuthate. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8791951
|
Jaup BH and Norrby A |
Comparison of two low-dose one-week triple therapy regimens with and without metronidazole for cure of H. pylori infection. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8791950
|
Delchier JC et al. |
Omeprazole-amoxycillin versus omeprazole-amoxycillin-clarithromycin in the eradication of Helicobacter pylori. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8791948
|
Peterson WL et al. |
Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. RBC H. pylori Study Group. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8791947
|
Gross U and Pohl F |
Influence of antimicrobial agents on replication and stage conversion of Toxoplasma gondii. |
1996 |
Curr. Top. Microbiol. Immunol. |
pmid:8791704
|
Mehaffey PC et al. |
Evaluation of in vitro spectra of activity of azithromycin, clarithromycin, and erythromycin tested against strains of Neisseria gonorrhoeae by reference agar dilution, disk diffusion, and Etest methods. |
1996 |
J. Clin. Microbiol. |
pmid:8789046
|
Welsh L et al. |
In vitro activities of azithromycin, clarithromycin, erythromycin, and tetracycline against 13 strains of Chlamydia pneumoniae. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8787907
|
Reid R et al. |
Pneumococcal meningitis during therapy of otitis media with clarithromycin. |
1995 |
Pediatr. Infect. Dis. J. |
pmid:8786899
|
Bagarazzi ML et al. |
Pulmonary Mycobacterium gordonae infection in a two-year-old child: case report. |
1996 |
Clin. Infect. Dis. |
pmid:8783736
|
Plemmons RM et al. |
Otitis media and mastoiditis due to Mycobacterium fortuitum: case report, review of four cases, and a cautionary note. |
1996 |
Clin. Infect. Dis. |
pmid:8783722
|
Apseloff G et al. |
Severe neutropenia caused by recommended prophylactic doses of rifabutin. |
1996 |
Lancet |
pmid:8782773
|
Roesch W |
Cost-effectiveness of H. pylori eradication. |
1996 |
J. Physiol. Pharmacol. |
pmid:8777309
|
Deltenre M et al. |
Strategies for Helicobacter pylori eradication in 1995: a review of international and Belgian experience. |
1996 |
J. Physiol. Pharmacol. |
pmid:8777308
|
Gabryelewicz A |
Critical evaluation of the treatment of peptic ulcer diseases associated with Helicobacter pylori infection. |
1996 |
J. Physiol. Pharmacol. |
pmid:8777307
|
Sito E et al. |
One week treatment with omeprazole, clarithromycin and tinidazole or lansoprazole, amoxicillin and metronidazole for cure of Helicobacter pylori infection in duodenal ulcer patients. |
1996 |
J. Physiol. Pharmacol. |
pmid:8777303
|
Berger C et al. |
Treatment of nontuberculous mycobacterial lymphadenitis with clarithromycin plus rifabutin. |
1996 |
J. Pediatr. |
pmid:8774511
|
Jordan WC |
Clarithromycin prophylaxis against Cryptosporidium enteritis in patients with AIDS. |
1996 |
J Natl Med Assoc |
pmid:8764523
|
Géhanno P et al. |
[Clarithromycin versus amoxicillin-clavulanic acid in the treatment of acute maxillary sinusitis in adults]. |
1996 |
Pathol. Biol. |
pmid:8763594
|
Sander P et al. |
Ribosomal drug resistance in mycobacteria. |
1996 Jan-Feb |
Res. Microbiol. |
pmid:8761724
|
Debets-Ossenkopp YJ et al. |
Mechanism of clarithromycin resistance in clinical isolates of Helicobacter pylori. |
1996 |
FEMS Microbiol. Lett. |
pmid:8759787
|
Tursi A et al. |
Short-term low-dose triple therapy with lansoprazole plus amoxycillin and clarithromycin for Helicobacter pylori eradication. |
1996 |
Am. J. Gastroenterol. |
pmid:8759696
|
Santander C et al. |
Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer: prospective nonrandomized trial on 125 patients. |
1996 |
Am. J. Gastroenterol. |
pmid:8759659
|
Sternon J et al. |
Azithromycin compared with clarithromycin in the treatment of adult patients with acute purulent tracheobronchitis: a cost of illness study. |
1995 Nov-Dec |
J. Int. Med. Res. |
pmid:8746608
|
Markham A and McTavish D |
Clarithromycin and omeprazole as helicobacter pylori eradication therapy in patients with H. pylori-associated gastric disorders. |
1996 |
Drugs |
pmid:8741237
|
Akamatsu H et al. |
Enhanced effect of clarithromycin on neutrophil function in vitro. |
1996 Mar-Apr |
J. Int. Med. Res. |
pmid:8737228
|
Lebrun L et al. |
Evaluation of the Etest for rapid susceptibility testing of Mycobacterium avium to clarithromycin. |
1996 |
J. Antimicrob. Chemother. |
pmid:8737150
|
Koga T et al. |
In-vitro and in-vivo antibacterial activity of plaunotol, a cytoprotective antiulcer agent, against Helicobacter pylori. |
1996 |
J. Antimicrob. Chemother. |
pmid:8737142
|
Cayla R |
[How to eradicate Helicobacter pylori?]. |
1996 |
Gastroenterol. Clin. Biol. |
pmid:8734380
|
Deltenre M et al. |
[How to eradicate Helicobacter pylori in 1995? Critical review of available treatments]. |
1996 |
Gastroenterol. Clin. Biol. |
pmid:8734370
|
Heifets LB |
Clarithromycin against Mycobacterium avium complex infections. |
1996 |
Tuber. Lung Dis. |
pmid:8733409
|
Bachelez H et al. |
Disseminated varioliform pustular eruption due to Mycobacterium avium intracellulare in an HIV-infected patient. |
1996 |
Br. J. Dermatol. |
pmid:8733397
|
Labenz J et al. |
One-week triple therapy with omeprazole, amoxycillin and either clarithromycin or metronidazole for cure of Helicobacter pylori infection. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8730252
|
Dalla Libera M et al. |
High effectiveness and safety of one-week antibiotic regimen in Helicobacter pylori eradication. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8730251
|
Gillum JG et al. |
Effect of clarithromycin on the pharmacokinetics of 2',3'-dideoxyinosine in patients who are seropositive for human immunodeficiency virus. |
1996 |
Clin. Infect. Dis. |
pmid:8729217
|
Darouiche RO et al. |
Recurrent disseminated infection with Mycobacterium avium complex identified in tissues by molecular analysis. |
1996 |
Clin. Infect. Dis. |
pmid:8729215
|
Vasquez A et al. |
Metronidazole and clarithromycin resistance in Helicobacter pylori determined by measuring MICs of antimicrobial agents in color indicator egg yolk agar in a miniwell format. The Gastrointestinal Physiology Working Group of Universidad Peruana Cayetano Heredia and the Johns Hopkins University. |
1996 |
J. Clin. Microbiol. |
pmid:8727909
|
Mertl SL |
The role of clarithromycin in the prophylaxis of disseminated Mycobacterium avium-intracellulare infection in patients with AIDS. |
1996 May-Jun |
Pharmacotherapy |
pmid:8726597
|
Arain TM et al. |
Bioluminescence screening in vitro (Bio-Siv) assays for high-volume antimycobacterial drug discovery. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8726034
|
Morikawa K et al. |
Modulatory effect of antibiotics on cytokine production by human monocytes in vitro. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8726002
|
|
H. pylori treatment recognized by FDA. |
1996 |
Am J Health Syst Pharm |
pmid:8725200
|
Barry AL et al. |
Reassessment of methods for testing the susceptibility of Haemophilus influenzae to clarithromycin. |
1996 |
J. Antimicrob. Chemother. |
pmid:8722555
|
Goddard AF and Logan RP |
Antimicrobial resistance and Helicobacter pylori. |
1996 |
J. Antimicrob. Chemother. |
pmid:8722530
|
Bazzoli F |
Italian omeprazole triple therapy--a 1-week regimen. |
1996 |
Scand. J. Gastroenterol. Suppl. |
pmid:8722395
|
Unge P |
Review of Helicobacter pylori eradication regimens. |
1996 |
Scand. J. Gastroenterol. Suppl. |
pmid:8722388
|
Lowe SH et al. |
Uveitis during treatment of disseminated Mycobacterium avium-intracellulare complex infection with the combination of rifabutin, clarithromycin and ethambutol. |
1996 |
Neth J Med |
pmid:8710040
|
Araki J et al. |
[A case of Mounier-Kuhn syndrome]. |
1996 |
Nippon Naika Gakkai Zasshi |
pmid:8708483
|
Meier A et al. |
Molecular mechanisms of clarithromycin resistance in Mycobacterium avium: observation of multiple 23S rDNA mutations in a clonal population. |
1996 |
J. Infect. Dis. |
pmid:8699066
|